A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
Conditions
Multiple Sclerosis Spasticity
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Alabama Neurology Associates, Birmingham, Alabama, United States
Perseverance Research Center,LLC, Scottsdale, Arizona, United States
Local Institution - 0017, Aurora, Colorado, United States
Aqualane Clinical Research, Naples, Florida, United States
USF Health, Tampa, Florida, United States
University of Kansas Medical Center, Kansas City, Kansas, United States
Neurology Center of New England, Foxborough, Massachusetts, United States
Local Institution - 0071, Southfield, Michigan, United States
Washington University School of Medicine, St Louis, Missouri, United States
University of Cincinnati Medical Center, Cincinnati, Ohio, United States
Riverside Methodist Hospital, Columbus, Ohio, United States
Local Institution - 0069, Columbus, Ohio, United States
Local Institution - 0067, Philadelphia, Pennsylvania, United States
Hope Neurology, Knoxville, Tennessee, United States
EvergreenHealth Medical Center, Kirkland, Washington, United States
John Hunter Hospital, Newcastle, New South Wales, Australia
University of Sydney - Brain and Mind Research Institute (BMRI), Sydney, New South Wales, Australia
Centre for Neuroscience Innovation, Kent Town, South Australia, Australia
Box Hill Hospital, Box Hill, Victoria, Australia
Austin Health, Heidelberg, Victoria, Australia
The Royal Melbourne Hospital, Parkville, Victoria, Australia
Perron Institute, Nedlands, Western Australia, Australia
University Of Alberta Hospital, Edmonton, Alberta, Canada
University Hospital - London Health Sciences Centre, London, Ontario, Canada
The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada
Unity Health Toronto, St. Michael's Hospital, Toronto, Ontario, Canada
Centre de Recherche Saint-Louis, Lévis, Quebec, Canada
Montreal Neurological Institute and Hospital, Montreal, Quebec, Canada
Fakultni Nemocnice u sv. Anny v Brne, Brno, Brno-město, Czechia
Fakultni nemocnice Hradec Kralove, Hradec Králové, Hradec Králové, Czechia
Vseobecna fakultni nemocnice v Praze, Prague, Praha 2, Czechia
Fakultni Thomayerova nemocnice, Prague, Praha 4, Czechia
Local Institution - 0011, Prague, Praha 5, Czechia
Nemocnice Pardubického kraje, Pardubice, Czechia
Nemocnice Teplice, Teplice, Ústí nad Labem Region, Czechia
Klinikum Würzburg Mitte, Würzburg, Bavaria, Germany
Neurologischen Gemeinschaftspraxis Kassel und Vellmar, Kassel, Hesse, Germany
St. Josef und St. Elisabeth Hospital gGmbH, Bochum, North Rhine-Westphalia, Germany
Universitätsklinikum Münster - Albert Schweitzer Campus, Münster, North Rhine-Westphalia, Germany
Local Institution - 0031, Meisenheim, Rhineland-Palatinate, Germany
Universitätsklinikum Jena, Jena, Thuringia, Germany
Neurozentrum Bielefeld, Bielefeld, Germany
Universitaetsklinikum Carl Gustav Carus Dresden, Dresden, Germany
Local Institution - 0020, Essen, Germany
Centrum Medyczne NEUROMED, Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
Local Institution - 0044, Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
Pratia MCM Krakow, Krakow, Lesser Poland Voivodeship, Poland
SP ZOZ Szpital Uniwersytecki w Krakowie, Krakow, Lesser Poland Voivodeship, Poland
Instytut Zdrowia Dr Boczarska Jedynak, Oświęcim, Lesser Poland Voivodeship, Poland
Centrum Medyczne NeuroProtect, Warsaw, Masovian Voivodeship, Poland
Local Institution - 0061, Gdansk, Poland
M.A. - LEK A.M. Maciejowscy S.C., Centrum Terapii SM, Katowice, Poland
Local Institution - 0051, Słomniki, Poland
Puerto Rico Multiple Sclerosis Center, Caguas, Puerto Rico
Study leads
Bristol-Myers Squibb
Study Director
Bristol-Myers Squibb